Clinical Trials Browser

OTHER × Gastric Adenocarcinoma × 30 days × Clear all

NCT07621562 2026-06-02

Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Adenocarcinoma